Publikation

Evidence for multiple sites of interaction between IL-12 and its receptor

Wissenschaftlicher Artikel/Review - 31.10.1996

Bereiche
PubMed

Zitation
Presky D, Minetti L, Gillessen Sommer S, Gubler U, Chizzonite R, Stern A, Gately M. Evidence for multiple sites of interaction between IL-12 and its receptor. Annals of the New York Academy of Sciences 1996; 795:390-3.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Annals of the New York Academy of Sciences 1996; 795
Veröffentlichungsdatum
31.10.1996
ISSN (Druck)
0077-8923
Seiten
390-3
Kurzbeschreibung/Zielsetzung

We have previously described the identification of a protein, now designated IL-12R beta 1, that binds 125I-huIL-12 with a Kd of about 10 nM, corresponding to the low affinity 125I-huIL-12 binding sites seen on PHA-activated human lymphoblasts. Using expression cloning techniques, we have recently identified an additional IL-12-binding protein subunit, IL-12R beta 2, which binds 125I-huIL-12 with a Kd of about 5 nM when expressed alone in COS-7 cells. Coexpression of IL-12R beta 1 and IL-12R beta 2 in COS-7 cells results in formation of two classes of 125 I-huIL-12-binding sites with Kds of about 50 pM and 5 nM. Mouse IL-12 p40 subunit homodimer (mo(p40)2) blocked 125I-huIL-12 binding to human IL-12R beta 1, but did not inhibit binding to human IL-12R beta 2. In contrast, anti-huIL-12 monoclonal antibody 20C2, which does not block 125I-huIL-12 binding to human IL-12R beta 1, completely blocked binding to human IL-12R beta 2. These results demonstrate that two classes of IL-12 inhibitors, one that primarily blocks IL-12/IL-12R beta 1 interaction (e.g., mo(p40)2), and one that primarily blocks IL-12/IL-12R beta 2 interaction (e.g., 20C2), can be identified.